Pasupuleti Giridhara Rao

Title: Innovations in Pharmaceutical Formulations: The Work of Pasupuleti Giridhara Rao

Introduction

Pasupuleti Giridhara Rao, an innovative inventor based in Nellore, India, has made significant contributions to the field of pharmaceuticals. With a keen focus on improving drug formulations, his research has culminated in a valuable patent that addresses the challenges in effective medication delivery.

Latest Patents

One of Pasupuleti's notable patents involves a pharmaceutical formulation that incorporates ezetimibe as an active ingredient. This invention relates to a composition that contains 5 to 20 wt-% ezetimibe, alongside a diluent comprising 50 to 85 wt-%, a disintegrant ranging from 3 to 25 wt-%, a binder making up 1 to 10 wt-%, and a lubricant of 0.5 to 1 wt-%. A key characteristic of this formulation is the specific particle size distribution of ezetimibe, with d(0.9) measuring between 5 µm to 35 µm and d(0.5) between 3 µm to 20 µm. The patent not only highlights the formulation but also outlines methods for its preparation, showcasing a significant advancement in pharmaceutical sciences.

Career Highlights

Pasupuleti Giridhara Rao is currently affiliated with Ratiopharm GmbH, a renowned pharmaceutical company committed to delivering high-quality medications. His expertise in formulation technology has played a crucial role in the company's innovative approaches to drug development.

Collaborations

In his professional journey, Pasupuleti has collaborated with talented coworkers such as Ganesh Vinayak Gat and Javed Hussain. Together, they work on pioneering projects aimed at enhancing pharmaceutical formulations and improving patient outcomes.

Conclusion

Pasupuleti Giridhara Rao's contributions to the field of pharmaceuticals, particularly through his patented formulation of ezetimibe, reflect his dedication to innovation. His work at Ratiopharm GmbH, along with collaborative efforts, continues to push the boundaries of what is possible in medication formulation, ultimately benefiting the medical community and patients alike.